International Stem Cell Corp (ISCO): Depreciation & Amortization
$219.0K
Year ended 2025-12-31
$171.0K
Trailing 12 months to 2026-06-30
+0.2%
3-year compound annual growth
-2.8%
5-year compound annual growth
-7.4%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $219.0K | +6.3% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $206.0K | +6.2% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $194.0K | -11.0% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $218.0K | -16.8% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $262.0K | +3.6% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $253.0K | -11.2% | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $285.0K | -7.5% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $308.0K | -5.5% | 2020-06-01, From 2018-01-01 |
| 2017-12-31 | $326.0K | -1.5% | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | $331.0K | -29.9% | 2018-04-09, From 2016-01-01 |
| 2015-12-31 | $472.0K | +3.1% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $458.0K | -1.3% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $464.0K | -2.1% | 2015-03-30, From 2013-01-01 |
| 2012-12-31 | $474.0K | -4.0% | 2014-03-17, From 2012-01-01 |
| 2011-12-31 | $494.0K | +70.9% | 2013-03-26, From 2011-01-01 |
| 2010-12-31 | $289.0K | n/a | 2012-03-16, From 2010-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| International Stem Cell Corp (ISCO) | 2025-12-31 | $219.0K | +6.3% |
| Precigen, Inc. (PGEN) | 2025-12-31 | $3.20M | -29.3% |
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | $895.0K | +0.2% |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | $3.35M | -76.2% |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $454.0K | -43.7% |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | $1.29M | -27.5% |
| Adagene Inc. (ADAG) | 2025-12-31 | $438.9K | -39.3% |
| Xenon Pharmaceuticals Inc. (XENE) | 2025-12-31 | $2.54M | -0.7% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $273.0K | -55.5% |
Compare ISCO, PGEN, PRTA, ROIV side by side · Screen every company in Pharmaceutical Preparations ↗